Elevation of blood beta-carboline alkaloids in essential tremor.
about
A variant in the HS1-BP3 gene is associated with familial essential tremorElevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremorAssociation between essential tremor and blood lead concentration.Blood harmane concentrations and dietary protein consumption in essential tremorQuantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of donenessPrenatal exposure to the organophosphate pesticide chlorpyrifos and childhood tremorCa(V)3.1 is a tremor rhythm pacemaker in the inferior oliveAge of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal studySemi-quantitative data on ethanol consumption in 354 ET cases and 370 controls.Dietary epidemiology of essential tremor: meat consumption and meat cooking practicesFunctional correlates of lower cognitive test scores in essential tremor.Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor casesBlood harmane, blood lead, and severity of hand tremor: evidence of additive effects.Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New YorkBlood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in dystonia cases vs. controls.Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls.The potential of LINGO-1 as a therapeutic target for essential tremor.Mediterranean diet and essential tremor. A case-control study.Reduced body mass index in essential tremor: a study of 382 cases and 392 matched controlsModulation of voltage-gated channel currents by harmaline and harmane.Blood harmane concentrations in 497 individuals relative to coffee, cigarettes, and food consumption on the morning of testing.Personality in essential tremor: further evidence of non-motor manifestations of the disease.Effect of Crocus sativus extracts and its active constituent safranal on the harmaline-induced tremor in mice.Tandem gait performance in essential tremor patients correlates with cognitive function.Kinetic tremor: differences between smokers and non-smokers.Depressive traits in essential tremor: impact on disability, quality of life, and medication adherence.Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management.Movement disorders and alcohol misuse.Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain.Familial Aggregation and Co-Aggregation of Essential Tremor and Parkinson's DiseaseSleep in essential tremor: a comparison with normal controls and Parkinson's disease patientsVoice handicap in essential tremor: a comparison with normal controls and Parkinson's diseaseReport from a U.S. conference on essential tremor.Essential tremor: emerging views of a common disorder.Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremorGenetic analysis of the FUS/TLS gene in essential tremor.Apathy in essential tremor, dystonia, and Parkinson's disease: a comparison with normal controls.Environmental epidemiology of essential tremor.Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls.Essential tremor is associated with dementia: prospective population-based study in New York.
P2860
Q24532036-E4BFD664-F9B7-4BE6-BEA7-B178ACB9F9A3Q24656692-867A7FEB-BFB0-4348-A6AE-37C06F2517C1Q24816661-DD980F97-2907-4716-937F-9E6BEEFD871CQ28266364-6649318D-2CF0-4AEF-815F-9B52DB43782AQ28302011-2760807C-C618-49C8-8EF3-9C58D5371C7BQ28390750-8A04D883-BB0B-48B4-962D-DB0E3321A0BCQ30495072-5938B8AC-3836-4E9E-9CC3-CBD36D733768Q30574622-6C10B7F8-0168-443D-94D7-BBB3D2731F28Q30857438-5E841B24-D413-4323-8AF2-028639F435BAQ33650983-6378B676-2165-45E3-AA63-5766781F3E60Q33760496-39296433-FC9B-4026-B483-CA3AE0D32C31Q33855255-14312D37-083C-4778-A618-975250F741EBQ34024964-6DE234E6-AA21-4022-8146-85D6A5A781AFQ34032624-AA576824-B582-4172-98C0-F7FE81134CD2Q34250523-41DF41AA-50EC-42D0-84AC-016A534A78B0Q34279991-EC284AF0-56CA-45CE-8970-ECD49DC17250Q34471202-9F23CAF0-0A4B-4F38-9397-C5AA37402EBCQ34536096-08005BE4-701C-4F59-BB0E-113DD0C53B86Q34899054-A8444C27-C931-4363-8B7E-31D4715FE8F3Q35048502-A31B6BE9-7790-46FA-A819-617C4A3C389AQ35102178-FF6931F5-4F15-43A1-BCB2-F4FCB5036609Q35482034-87E9165F-F861-41C3-AA84-ACFCD7A6F223Q35763443-D46327FB-FC11-4F7D-9F8D-139B32D2C8D6Q36003250-704819DD-63AA-412E-88BF-4F8BDF7A1A93Q36052382-0B815486-2CE0-4C75-955E-D1385FCAE8CFQ36210177-9E6AC1F5-04B5-42A8-B5A8-538959A22927Q36235520-ADDB9E18-FFE7-4AB6-8671-5C9820D7206CQ36519440-1387583A-9840-4706-BC94-E5590F890B37Q36565922-9FC3A14A-004B-4696-A911-B87BEB1D874AQ36608484-1C83965C-2AF3-4A0C-8639-84681BB966BDQ36610164-632A5F5D-71B6-4088-9981-85C2E37ED82FQ36640323-4227B56A-1F04-4637-A519-8D1B8551D3E0Q36641019-E29CF2A4-BF2E-4DA5-8F3A-C852BE355573Q36658868-AA1790B9-87FD-4275-8603-161EEF03218DQ36796439-9E299592-D58F-42E1-BBE2-09C96FF5DCAAQ36888348-C043BE98-D038-4532-8693-77F5520165D1Q36934428-1FE53878-EF09-43E2-92CF-9D5FB7C4E7ADQ37196824-D646A503-CA01-4919-9DE8-C2001FF8F53EQ37200585-9A8E8C59-AFBB-4C59-8547-BC0EB8ADE522Q37317671-151BD9FB-9A9E-4E6A-8FA7-442B568E16D9
P2860
Elevation of blood beta-carboline alkaloids in essential tremor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Elevation of blood beta-carboline alkaloids in essential tremor.
@ast
Elevation of blood beta-carboline alkaloids in essential tremor.
@en
Elevation of blood beta-carboline alkaloids in essential tremor.
@nl
type
label
Elevation of blood beta-carboline alkaloids in essential tremor.
@ast
Elevation of blood beta-carboline alkaloids in essential tremor.
@en
Elevation of blood beta-carboline alkaloids in essential tremor.
@nl
prefLabel
Elevation of blood beta-carboline alkaloids in essential tremor.
@ast
Elevation of blood beta-carboline alkaloids in essential tremor.
@en
Elevation of blood beta-carboline alkaloids in essential tremor.
@nl
P2093
P2860
P1433
P1476
Elevation of blood beta-carboline alkaloids in essential tremor.
@en
P2093
E C Jurewicz
P Factor-Litvak
P2860
P304
P356
10.1212/01.WNL.0000038385.60538.19
P407
P577
2002-12-01T00:00:00Z